Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

BPC-157 + TB-500 10mg Blend Dosage Protocol | PeptideDosages.com

BPC-157 + TB-500 (10 mg Blend) Dosage Protocol BPC-157 + TB-500 Dosage Chart The BPC-157 + TB-500 peptide blend is dosed at 600 mcg–800 mcg daily via subcutaneous injection in educational protocols. A 10 mg blend reconstituted with bacteriostatic water yields

BPC-157 + TB-500 (10 mg Blend) Dosage Protocol

BPC-157 + TB-500 Dosage Chart

The BPC-157 + TB-500 peptide blend is dosed at 600 mcg–800 mcg daily via subcutaneous injection in educational protocols. A 10 mg blend reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only.

Reconstitute: Add 3.0 mL bacteriostatic water → 3.33 mg/mL total concentration (1.67 mg/mL of each peptide).

Typical daily range: 600–1000 mcg total blend once daily (provides 300–500 mcg of each peptide).

Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg total blend on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

This blend combines two well-studied regenerative peptides: BPC-157 (Body Protection Compound-157), a pentadecapeptide derived from human gastric juice with cytoprotective and wound-healing properties[1][2], and TB-500 (Thymosin Beta-4 fragment), a 43-amino-acid peptide involved in tissue repair, cell migration, and angiogenesis[3][4]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Related research: For distinct compound, component, or formulation evidence and safety context, read BPC-157 Peptide: Benefits, Uses, Side Effects, Dosage, and Research and TB-500 Peptide: Benefits, Uses, Side Effects, Dosage, and Research. These links are comparisons only; the compounds and formulations should not be treated as interchangeable.

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Route: Subcutaneous injection, once daily[5][6]. This blend contains equal amounts of BPC-157 and TB-500 (5 mg each); every dose drawn provides a 1:1 ratio of both peptides.

Weeks 1–2 (Initial)

600 mcg

300 mcg BPC + 300 mcg TB-500

18 units (0.18 mL)

Weeks 3–4 (Loading)

800 mcg

400 mcg BPC + 400 mcg TB-500

24 units (0.24 mL)

Weeks 5–8 (Maintenance)

Frequency: Inject once daily subcutaneously. This schedule uses 3.0 mL dilution to keep per-injection volumes ≥18 units for accurate measurement. Rotate injection sites systematically[7].

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming or vigorous shaking.

Gently swirl/roll until fully dissolved (do not shake).

Label with date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Advanced / Aggressive Approach (Acute Injury Support)

For acute tissue injuries, some protocols suggest a higher initial loading phase[8][9]. This approach uses higher daily doses during the first 4 weeks before tapering to maintenance. Use with caution; robust human dose-finding data remain limited.

Weeks 1–2 (Aggressive Load)

1000 mcg

500 mcg BPC + 500 mcg TB-500

30 units (0.30 mL)

Weeks 3–4 (High Load)

Note: A small human case series combining BPC-157 and TB-500 for joint injuries reported improved outcomes at higher combined doses (4 mg BPC + 6 mg TB-500 intra-articular) compared to lower doses[8]. However, systemic subcutaneous protocols typically use the ranges above. Treatment duration is generally limited to 8–12 weeks before cycling off to evaluate response[9].

Supplies Needed

Plan based on an 8–16 week daily protocol with phased dosing (averaging ~700 mcg/day over the cycle).

Peptide Vials (BPC-157 + TB-500, 10 mg blend each):

8 weeks ≈ 4 vials

12 weeks ≈ 6 vials

16 weeks ≈ 8 vials

Insulin Syringes (U-100):

Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

8 weeks (4 vials): 12 mL → 2 × 10 mL bottles

12 weeks (6 vials): 18 mL → 2 × 10 mL bottles

16 weeks (8 vials): 24 mL → 3 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

16 weeks: 224 swabs → recommend 3 × 100-count boxes